TY - JOUR
KW - Adult
KW - Benzodiazepines/urine
KW - Buprenorphine/therapeutic use
KW - Cocaine/urine
KW - Community Health Services/organization & administration
KW - Counseling
KW - Drug Therapy, Combination
KW - Female
KW - Humans
KW - Indians, North American
KW - Male
KW - Medication Adherence/statistics & numerical data
KW - Middle Aged
KW - Morphine/urine
KW - Naloxone/therapeutic use
KW - Narcotic Antagonists/therapeutic use
KW - Ontario
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy/ethnology
KW - Oxycodone/urine
KW - Program Evaluation
KW - Retrospective Studies
KW - Rural Health Services/organization & administration
KW - Substance Abuse Detection
KW - Suicide/trends
KW - Young Adult
AU - S. Mamakwa
AU - M. Kahan
AU - D. Kanate
AU - M. Kirlew
AU - D. Folk
AU - S. Cirone
AU - S. Rea
AU - P. Parsons
AU - C. Edwards
AU - J. Gordon
AU - F. Main
AU - L. Kelly
A1 - 
BT - Canadian family physician Medecin de famille canadien
C5 - Opioids & Substance Use; Healthcare Disparities
CP - 2
CY - Canada
IS - 2
JF - Canadian family physician Medecin de famille canadien
PP - Canada
PY - 2017
SN - 1715-5258; 0008-350X
SP - 137
EP - 145
EP - 
T1 - Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario: Retrospective study
T2 - Canadian family physician Medecin de famille canadien
TI - Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario: Retrospective study
U1 - Opioids & Substance Use; Healthcare Disparities
U2 - 28209683
VL - 63
VO - 1715-5258; 0008-350X
Y1 - 2017
ER -